TORONTO–(BUSINESS WIRE)– #FSDDF–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced the sale of its 12% equity interest in Cannara Biotech Inc. (CSE: LOVE) (“Cannara”) to a consortium of buyers for cash proceeds of more than $7.7 million (the “Share Sale Transaction”). The terms of the Share Sale Transaction were negotiated at arm’s length with a group of buyers that included entities controlled by members of the Cannara board and senior management.

READ MORE: https://www.businesswire.com/news/home/20200219006059/en/FSD-Pharma-Generates-7.7-Million-Proceeds-670/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhB8bDel5XZmwWFQYQPHxx__rCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3kCXJZE-1b1nXn968wYfofVLkaZDLiczsahzEklD3R10Q==